SERCA2

Last updated on: 30.04.2025

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

SERCA2 is a Ca²⁺-ATPase that pumps calcium ions (Ca²⁺) from the cytoplasm into the sarcoplasmic/endoplasmic reticulum using energy (ATP). The enzyme is encoded by the ATP2A2 gene, which is localized on chromosome 12q24.11. SERCA2 has two main isoforms:

  • SERCA2a: mainly in the heart muscle (cardiomyocytes) and in slow skeletal muscle fibers - important for relaxation after contraction.
  • SERCA2b: ubiquitously expressed, constitutively active - higher affinity for Ca²⁺, but lower transport speed.

General informationThis section has been translated automatically.

Calcium-pumping ATPases have the task of maintaining a low cytoplasmic concentration of Ca2+ ions. They are transporters with high affinity and low capacity. The enzyme is also involved in the following biological processes:

  • Autophagy in response to starvation
  • Controls ER isolation membrane contacts for autophagosome formation after interaction with VMP1 and activation
  • Also modulates ER contacts with lipid droplets, mitochondria and endosomes
  • SERCA2 is involved in the regulation of the contraction/relaxation cycle of the muscle cell
  • Acts as a regulator of TNFSF11-mediated Ca(2+) signaling pathways via its interaction with TMEM64, which is responsible for TNFSF11-induced CREB1 activation and mitochondrial ROS formation required for proper osteoclast formation.

AtPase activity is modulated by phospholamban (PLN) in cardiac muscle. Non-phosphorylated PLN inhibits SERCA2a. Phosphorylated PLN (e.g. by β-adrenaline stimulation) removes the inhibition. The activity can also be regulated by post-translational modifications (e.g. oxidation, phosphorylation).

PathophysiologyThis section has been translated automatically.

Heart failure: reduced SERCA2a activity leads to impaired Ca²⁺ recycling and contraction weakness.

Dyskeratosis follicularis: mutations in the ATP2A2 gene lead to impaired cell adhesion

LiteratureThis section has been translated automatically.

  1. Korosec B et al. (2006) Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genet Cytogenet 171:105-111
  2. Ren YQ et al. (2006) Five mutations of ATP2A2 gene in Chinese patients with Darier's disease and a literature review of 86 cases reported in China. Arch Dermatol Res 298:58-63.
  3. Zhao YG et al. (2018) The ER-localized autophagy protein EPG-3/VMP1 regulates ER contacts with other organelles by modulating ATP2A/SERCA activity. Autophagy 14:362-363.

Last updated on: 30.04.2025